Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial.
Arenas-Pinto A, Grund B, Sharma S, Martinez E, Cummins N, Fox J, Klingman KL, Sedlacek D, Collins S, Flynn PM, Chasanov WM, Kedem E, Katlama C, Sierra-Madero J, Afonso C, Brouwers P, Cooper DA; INSIGHT START study group.
Arenas-Pinto A, et al. Among authors: afonso c.
Clin Infect Dis. 2018 Jul 18;67(3):420-429. doi: 10.1093/cid/ciy051.
Clin Infect Dis. 2018.
PMID: 29538636
Free PMC article.
Clinical Trial.